Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT03370952
Collaborator
(none)
112
1
2
19.4
5.8

Study Details

Study Description

Brief Summary

Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es).

Aspiration of the cyst:

Veress needle is inserted in the midline 2 cm above the symphysis pubis to aspirate the cyst under laparoscopic guidance (to guide the entry of the needle into the cyst wall & to confirm complete aspiration).

Delivery of affected ovary outside the abdominal cavity:

Classic ovarian cystectomy will be done using microsurgical techniques in which the cyst wall will be dissected gently and carefully from the healthy ovarian tissue followed by perfect haemostasis and re-fashioning of the remaining ovarian tissue using Vicryl (3-0) sutures.

Re-introduction of the ovary to inside the abdominal cavity:

The stitched ovary is pushed gently inside the abdominal cavity and the mini-laparotomy is re-covered by the rubber shield (to allow re-inflation of the abdominal cavity). The ovary is reassessed under laparoscopic guidance to ensure perfect haemostasis and normal position of the ovary. Pelvic irrigation is done if needed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: laproscopy
  • Procedure: combined laproscopic and minilaparotomy ovarian cystectomy
N/A

Detailed Description

Patient positioning and port placement:

Under general anaesthesia, the patient is placed in themodified dorsal lithotomy position (to ensure lax anterior abdominal wall). The patient is thenprepped and draped in the usual fashion for an abdominaland vaginal procedure. In non- virgin patients, vaginal speculum is inserted into thevagina to expose the cervix, a uterine manipulator is inserted in the cervix followed by placement of a Foley's catheter in thebladder. As regards port placement, a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es).

Aspiration of the cyst:

Veress needle is inserted in the midline 2 cm above the symphysis pubis to aspirate the cyst under laparoscopic guidance (to guide the entry of the needle into the cyst wall & to confirm complete aspiration).

Delivery of affected ovary outside the abdominal cavity:

A transverse mini-laparotomy is done (2-3 cm) in the midline 2 cm above the symphysis pubis. A long shanks artery forceps is introduced inside the abdominal cavity (to grasp the affected ovary) under laparoscopic guidance. Then, the artery is pulled gently to the outside to deliver the ovary at the mini-laparotomy skin incision. Careful handling and traction is applied to avoid injury of both the ovarian tissue or/andinfundibulopelvic ligament. Following the delivery of the ovary, the abdominal incision is temporary closed using (E-shaped 10 x 10 cm) rubbershield (to avoid any soiling of abdominal cavity with blood or cystic fluid & give the chance to reinflate the abdominal cavity later on).

Ovarian cystectomy:

Classic ovarian cystectomy will be done using microsurgical techniques in which the cyst wall will be dissected gently and carefully from the healthy ovarian tissue followed by perfect haemostasis and re-fashioning of the remaining ovarian tissue using Vicryl (3-0) sutures.

Re-introduction of the ovary to inside the abdominal cavity:

The stitched ovary is pushed gently inside the abdominal cavity and the mini-laparotomy is re-covered by the rubber shield (to allow re-inflation of the abdominal cavity). The ovary is reassessed under laparoscopic guidance to ensure perfect haemostasis and normal position of the ovary. Pelvic irrigation is done if needed.

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH
Actual Study Start Date :
Dec 21, 2017
Actual Primary Completion Date :
Jul 5, 2019
Actual Study Completion Date :
Aug 3, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: new approach

Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es). Aspiration of the cyst: Delivery of affected ovary outside the abdominal cavity: A transverse mini-laparotomy is done (2-3 cm) in the midline 2 cm above the symphysis pubis. Ovarian cystectomy: Re-introduction of the ovary to inside the abdominal cavity:

Procedure: combined laproscopic and minilaparotomy ovarian cystectomy
Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es). Aspiration of the cyst:Delivery of affected ovary outside the abdominal cavity: Ovarian cystectomy: Re-introduction of the ovary to inside the abdominal cavity:

Active Comparator: Laproscopic ovarian cystectomy

classic laparoscopic ovarian cystectomy

Procedure: laproscopy
laparoscopic ovarian cystectomy

Outcome Measures

Primary Outcome Measures

  1. recurrence of ovarian masses [6 months after the operation]

    recurrence was defined as the presence of ovarian cysts ≥2 cm in the ipsilateral ovary

Secondary Outcome Measures

  1. serum follicle stimulating hormone [6 months after the operation]

    Measurement of FSH on 2nd day of a natural cycle as a marker of ovarian reserve

  2. Serum antimullerian hormone [6 months after the operation]

    Measurement of AMH on 2nd day of a natural cycle as a marker of ovarian reserve

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • unilateral or bilateral ovarian cysts (≥ 10 cm),

  • recurrent ovarian cysts

  • good ovarian reserve (antimullerian hormone > 1 ng/ml & antral follicular count > 4)

Exclusion Criteria:
  • solid ovarian masses

  • patients who were unfit for surgery

  • chronic diseases (e.g. cardiac disease or diabetes)

  • any contraindication for laparoscopic surgery (excessive anterior abdominal wall scarring)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Alainy medical school Cairo Egypt 12151

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Ahmed Maged, MD, Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed M Maged, MD, professor, Cairo University
ClinicalTrials.gov Identifier:
NCT03370952
Other Study ID Numbers:
  • 15
First Posted:
Dec 13, 2017
Last Update Posted:
Jan 11, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2022